Which pill works best for tough ringworm? new study aims to find out

NCT ID NCT07342153

Recruiting now Disease control Sponsor: Urooj Fatima Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two common oral antifungal pills—fluconazole and itraconazole—in adults with ringworm that hasn't cleared up with creams. 126 people aged 18-70 with persistent infection for at least 6 months will be randomly assigned to one of the two drugs for 4 weeks. The goal is to see which one completely clears the rash, itching, and scaling.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fluconazole and itraconazole (oral antifungal drugs)
What this could lead to: If this trial succeeds, it could help doctors choose the most effective oral antifungal for stubborn ringworm infections, improving treatment success and quality of life.
What could go wrong: This is a small, single-center Phase 4 trial. Results may not apply to all populations, and neither drug may work well for everyone with resistant infections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMATOPHYTOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dermatophytosis Tinea tinea corporis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DERMATOPHYTOSIS TINEA CORPORIS

Contacts and locations

Show contact details

Locations

CDA Hospital Islamabad
RECRUITING

Islamabad, Punjab Province, 46000, Pakistan

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.